Lothar MAYER
Lothar MAYER publishes mostly in Molecular Biology, Endocrinology, Diabetes and Metabolism and Neurology, on topics such as Metabolism, Diabetes, and Cancer, Diabetes Treatment and Management and Coagulation, Bradykinin, Polyphosphates, and Angioedema.
- World rank
- #5,796,836 of 7,710,434 ranked researchers
- Rank in Germany
- #297,659 of 364,343
- Works
- 15
- Citations
- 174
- Citations per work
- 11.6
What does Lothar MAYER research?
Lothar MAYER's work is mostly in Medicine (42%), Biochemistry, Genetics and Molecular Biology (18%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences642.2%
- Medicine642.2%
- Everything else639.4%
- Life Sciences318.4%
- 1Molecular Biology18% of their works
- 2Endocrinology, Diabetes and Metabolism13% of their works
- 3Neurology8% of their works
- 4Pharmacology8% of their works
- 5Genetics8% of their works
- 6Complementary and alternative medicine5% of their works
Research topics
- Metabolism, Diabetes, and Cancer
- Diabetes Treatment and Management
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- CNS Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Pharmacology and Obesity Treatment
- Muscle metabolism and nutrition
Which keywords describe Lothar MAYER's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, AMP-Activated Protein Kinase, Cardiovascular Outcomes, Hereditary Angioedema, Kinin Receptor Family, Metformin and Type 2 Diabetes.
- Protein
- Prognostic Scoring System
- Pharmacotherapy
- Lymphoma
- Critical Care
- Type 2 Diabetes
- Kinin Receptor Family
- Cardiovascular Outcomes
- Insulin Therapy
- Glycemic Control
- AMP-Activated Protein Kinase
- Hereditary Angioedema
- Metformin
- Classification
- Hyperglycemia
- Obesity
- Primary CNS Lymphoma
- Metabolism
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Glycemic Control52 topics
- Insulin Therapy52 topics
- AMP-Activated Protein Kinase31 topic
- Cardiovascular Outcomes31 topic
- Hereditary Angioedema31 topic
- Kinin Receptor Family31 topic
- Metformin31 topic
- Type 2 Diabetes31 topic
- Classification21 topic
- Critical Care21 topic
- Hyperglycemia21 topic
- Lymphoma21 topic
- Obesity21 topic
- Pharmacotherapy21 topic
- Primary CNS Lymphoma21 topic
- Prognostic Scoring System21 topic
- Metabolism11 topic
- Protein11 topic
Where does Lothar MAYER work?
Lothar MAYER's main affiliation in the publication record is München Klinik Schwabing, Germany.
How many publications and citations does Lothar MAYER have?
OpenAlex counts 15 works and 174 citations for Lothar MAYER, an h-index of 7, ranking #5,796,836 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Lothar MAYER. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.